Candel Therapeutics Statistics Share Statistics Candel Therapeutics has 54.9M
shares outstanding. The number of shares has increased by 23.44%
in one year.
Shares Outstanding 54.9M Shares Change (YoY) 23.44% Shares Change (QoQ) 2.96% Owned by Institutions (%) 41.98% Shares Floating 37.78M Failed to Deliver (FTD) Shares 520 FTD / Avg. Volume 0.06%
Short Selling Information The latest short interest is 7.43M, so 13.54% of the outstanding
shares have been sold short.
Short Interest 7.43M Short % of Shares Out 13.54% Short % of Float 17.1% Short Ratio (days to cover) 8.06
Valuation Ratios The PE ratio is -4.98 and the forward
PE ratio is -6.16.
Candel Therapeutics's PEG ratio is
-0.15.
PE Ratio -4.98 Forward PE -6.16 PS Ratio 0 Forward PS 3.2 PB Ratio 4.15 P/FCF Ratio -10.17 PEG Ratio -0.15
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Candel Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.77,
with a Debt / Equity ratio of 0.2.
Current Ratio 2.77 Quick Ratio 2.77 Debt / Equity 0.2 Debt / EBITDA -0.26 Debt / FCF -0.5 Interest Coverage -15.97
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.45M Employee Count 38 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -19.37% in the
last 52 weeks. The beta is -0.93, so Candel Therapeutics's
price volatility has been lower than the market average.
Beta -0.93 52-Week Price Change -19.37% 50-Day Moving Average 5.68 200-Day Moving Average 6.43 Relative Strength Index (RSI) 51.55 Average Volume (20 Days) 809,211
Income Statement
Revenue n/a Gross Profit -990K Operating Income -33.37M Net Income -55.18M EBITDA -52.1M EBIT -53.09M Earnings Per Share (EPS) -1.74
Full Income Statement Balance Sheet The company has 102.65M in cash and 13.47M in
debt, giving a net cash position of 89.18M.
Cash & Cash Equivalents 102.65M Total Debt 13.47M Net Cash 89.18M Retained Earnings -192.21M Total Assets 105.97M Working Capital 88.89M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -27.02M
and capital expenditures -16K, giving a free cash flow of -27.04M.
Operating Cash Flow -27.02M Capital Expenditures -16K Free Cash Flow -27.04M FCF Per Share -0.85
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
